Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation

Details for Australian Patent Application No. 2009273259 (hide)

Owner Novartis AG

Inventors Ahmed, Syed Sohail; Londei, Marco; Wright, Timothy; Gergely, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2009273259

PCT Pub. Number WO2010/010127

Priority 08161005.7 23.07.08 EP

Filing date 22 July 2009

Wipo publication date 28 January 2010

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/010127 Priority application(s): WO2010/010127

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009273263-Nacelle of a wind turbine comprising aviation obstruction lights

2009273251-Amino acid sequences directed against multitarget scavenger receptors and polypeptides